期刊文献+

吸入性糖皮质激素治疗支气管哮喘的概况 被引量:2

下载PDF
导出
摘要 采用吸入性糖皮质激素(inhaled corticosteroid ICS)治疗儿童或成人慢性支气管哮喘是支气管哮喘治疗的一项重要措施。因其有效的治疗作用及能有效改善疾病预后,在临床上有较广泛的运用。本文将对此领域作一综述。
作者 方立生
出处 《中国实用医药》 2008年第3期157-158,共2页 China Practical Medicine
  • 相关文献

参考文献14

  • 1[1]Brown HM,Storey G,George WH,et al.Beclomethasone dipropionate:A new steroid aerosol for the treatment of allergic asthma.Br Med J,1972,1 (5800):585-590.
  • 2[2]Busse WW,Romagnoli M,Corbetta L,et al.Asthma.N Engl J Med,2001,344(5):350-362.
  • 3[3]Fardon TC,Lee DKC,Haggar K,et al.Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.Am J Respir Crit Care Med,2004,170 (9):960-966.
  • 4[4]Sin DD,Man J,Sharpe H,Gan wo,et al.Phaumacological management to reduce exacerbations in adults with asthma:a systematic review and meta-analysis.JAMA,2004,292 (3):367-376.
  • 5[5]National Asthma Edution and Prevention Program (NAEPP).[internet].Available at www.nhlbi.gov/about/naepp/index.htm.(Acessed May 10,2007).
  • 6[6]Edmonds ML,Camargo CA Jr,Pollack CV Jr,et al.Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.Cochrane Databade Syst Rev,2003 (3):CD002308.
  • 7[7]O' Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2001,164 (8pt 1):1392-1397.
  • 8[8]Boushey HA,Sorkness CA,King TS,et al.National Heart,Lung,and Blood Institute's Asthma Clinical Research NetWork.Daily versus asneeded corticosteroids for mild persistent asthma.N Engl J Med,2005,352(15):1519-1528.
  • 9[9]Ward C,Pais M,Bish R,et al.Airway inflammation,basement membrane thickening and bronchial hyperresponsiveness in asthma.Thorax,2002,57(4):309-316.
  • 10[10]Jones A,Fay JK,Burr M,et al.Inhaled corticosteroid effects on bone metabolism in asthma and mild chromic obstructive pulmonary disease.Cochrane Database Syst Rev,2002,(1):CD003537.

同被引文献18

  • 1梁蕊,邵玉霞,王宏伟.吸入糖皮质激素对哮喘大鼠气道炎症和气道重构的影响[J].哈尔滨医科大学学报,2006,40(2):140-143. 被引量:3
  • 2Bateman ED,Hurd SS,Barnes PJ,et al.Global strategy for asthma management and prevention:GINA executive summary[J].Eur Respir J,2008,31(1):143-178.
  • 3Elias JA.Airway remodeling in asthma.Unanswered questions[J].Am J Respir Crit Care Med,2000,161(3 Pt2):S168-S171.
  • 4Busse WW,Romagnoli M,Corbetta L,et al.Asthma[J].N Engl J Med,2001,344(5):350-362.
  • 5Vanacker NJ,Palmans E,Kips JC,et al.Fluticasone inhibits but does not reverse allergen-induced structural airway changes[J].Am J Respir Crit Care Med,2001,163(3):674-679.
  • 6Watson CS,Gametchu B.Proteins of multiple classes may participate in nongenomic steroid actions[J].Exp Biol Med (Maywood),2003,228(11):1272-1281.
  • 7Liu C,Zhou J,Zhang LD,et al.Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells[J].Horm Metab Res,2007,39(4):273-277.
  • 8Zhou J,Kang ZM,Xie QM,et al.Rapid nongenomic effects of glucocorticoids on allergic asthma reaction in the guinea pig[J].J Endocrinol,2003,177(1):R1-R4.
  • 9Zhou J,Liu DF,Liu C,et al.Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism[J].Allergy,2008,63(9):1177-1185.
  • 10Stahn C,Buttgereit F.Genomic and nongenomic effects of gluco-corticoids[J].Nat Clin Pract Rheumatol,2008,4(10):525-533.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部